COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Amgen

Large biopharmaceutical company with a strong biologics franchise and significant oncology and inflammation portfolios.

TICKERAMGN

HEADQUARTERSCalifornia, USA

STAGEApproved

ACTIVE TRIALS101

Therapeutic areas

Oncologyinflammationbone healthcardiovascular

Selected products and programs

EnbrelProliaRepatha

Linked curated drug profiles

No curated drug entity is linked in the current pilot.

Selected active clinical trials

A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Phase 3 · Recruiting · Secondary Hyperparathyroidism

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Phase 3 · Recruiting · Non-Small Cell Lung Cancer (NSCLC)

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Phase 3 · Recruiting · Neovascular Age-related Macular Degeneration

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

Phase 3 · Recruiting · Small Cell Lung Cancer

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Phase 3 · Recruiting · Obstructive Sleep Apnea

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Phase 3 · Recruiting · Obesity

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

www.amgenpipeline.com ↗

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier: /companies/amgen/
Event / action date: Not separately retained
Source update date: Not separately retained
Platform retrieval / processing date: Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record